Genetic and Molecular Testing Changing How Melanoma Is Diagnosed and Treated

Share this article:

A growing arsenal of genetic and molecular tests is changing how clinicians diagnose and treat melanoma, however, clinicians must be careful when using them.

A growing arsenal of genetic and molecular tests is changing how clinicians diagnose and treat melanoma, according to Emily Chu, MD, PhD, assistant professor of dermatology, and pathology and laboratory medicine at the University of Pennsylvania, Philadelphia.

However, she said clinicians must be careful when using many of these new testing kits.

Dr Chu, who spoke about the optimal use of new molecular tests at the American Academy of Dermatology 74th Annual Meeting in March 2016, said a new generation of detection kits offer a wide variety of options.1